Generate Biomedicines, Inc. Common Stock Share Price
NASDAQ: GENB
Live Generate Biomedicines, Inc. Common Stock Share Price Chart
O H L
Generate Biomedicines, Inc. Common Stock Performance Overview
Days Range
▼
$16.57Low
$17.28High
Markets Today
| Previous Close | $17.12 |
|---|---|
| Open | $17.27 |
| Volume | 353,372 |
| Day's Range | $16.57 - $17.28 |
| 52W Range | NA |
| Market Cap | $2.01 B |
Historical Performance
| 1M Returns | +6.47 |
|---|---|
| 3M Returns | +18.15 |
| 6M Returns | +44.96 |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
Generate Biomedicines, Inc. Common Stock Fundamentals
| Market Cap | $2.01 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
| Market Cap | $2.01 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
Generate Biomedicines, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Total Revenue + | $7.22 M | $6.31 M |
| Gross Profit + | $7.22 M | $6.31 M |
| Operating Income | -$64.11 M | -$71.61 M |
| EBITDA | -$60.84 M | -$68.39 M |
| Interest Expense | -$182.00 K | -$155.00 K |
| Depreciation | $3.27 M | $3.22 M |
| Income Before Tax | -$61.69 M | -$67.20 M |
| Income Tax Expense | $28.00 K | $53.00 K |
| Net Income + | -$61.71 M | -$67.25 M |
| Net Profit Margin | -854.29% | -1065.17% |
Generate Biomedicines, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Share Capital | $128.00 K | $128.00 K |
| Reserve & Surplus | -$737.72 M | -$805.12 M |
| Non-Current Liabilities | $52.55 M | $49.01 M |
| Current Liabilities | $58.39 M | $56.64 M |
| Total Liabilities | $110.94 M | $105.64 M |
| Fixed Assets | $27.84 M | $27.30 M |
| Current Assets | $535.39 M | $470.25 M |
| Total Assets | $625.74 M | $561.69 M |
Generate Biomedicines, Inc. Common Stock Cash Flow
Quarterly
| Mar 2026 | Jun 2026 | |
|---|---|---|
| Net Income | -$61.71 M | -$67.25 M |
| Operating Cash Flow | -$80.39 M | -$57.94 M |
| Investing Cash Flow | -$259.93 M | $33.31 M |
| Financing Cash Flow | $378.89 M | -$579.00 K |
| Change in Cash | $38.57 M | -$25.21 M |
Generate Biomedicines, Inc. Common Stock Return Calculator
The Generate Biomedicines, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Generate Biomedicines, Inc. Common Stock
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Popular Stocks
FAQs
What is the share price of Generate Biomedicines, Inc. Common Stock today?
Generate Biomedicines, Inc. Common Stock (GENB) share price as of September 18, 2026 is $16.60. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Generate Biomedicines, Inc. Common Stock?
Yes, Indian Investors can invest in the Generate Biomedicines, Inc. Common Stock (GENB) Share by opening an international trading account with Angel One.
How can I purchase Generate Biomedicines, Inc. Common Stock shares in India?
Purchasing Generate Biomedicines, Inc. Common Stock (GENB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Generate Biomedicines, Inc. Common Stock (GENB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Generate Biomedicines, Inc. Common Stock?
Yes, you can purchase fractional shares of Generate Biomedicines, Inc. Common Stock (GENB) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Generate Biomedicines, Inc. Common Stock?
The market capitalization of Generate Biomedicines, Inc. Common Stock on September 18, 2026, is $2.01 B.
In which sector Generate Biomedicines, Inc. Common Stock belongs?
Generate Biomedicines, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Generate Biomedicines, Inc. Common Stock stocks?
In order to invest in Generate Biomedicines, Inc. Common Stock (GENB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
